MAPKs as Mediators of Cell Fate Determination: an Approach to Neurodegenerative Diseases

E-ISSN： 1875-533x|15|6|538-548

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.15, Iss.6, 2008-03, pp. : 538-548

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nanotechnology and Antioxidant Therapy: An Emerging Approach for Neurodegenerative Diseases

Current Medicinal Chemistry, Vol. 21, Iss. 38, 2014-12 ,pp. : 4311-4327

Bentham Science Publishers

Access to resources Recommend Favorite

Oxidative Stress and Neurodegenerative Diseases: A Neurotrophic Approach

Current Drug Targets, Vol. 16, Iss. 1, 2015-01 ,pp. : 20-30

Bentham Science Publishers

Access to resources Recommend Favorite

Potentials of ES Cell Therapy in Neurodegenerative Diseases

Current Pharmaceutical Design, Vol. 14, Iss. 36, 2008-12 ,pp. : 3873-3879

Bentham Science Publishers

Access to resources Recommend Favorite

Human Embryonic Stem Cell Therapies for Neurodegenerative Diseases

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 4, 2011-06 ,pp. : 440-448

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Imaging of Stem Cell Transplantation for Neurodegenerative Diseases

Current Pharmaceutical Design, Vol. 18, Iss. 28, 2012-09 ,pp. : 4426-4440

Bentham Science Publishers

Access to resources Recommend Favorite